US$ 20.73
long term side effects of glp-1 receptor agonists Adverse Overdose risks increase as demand
Description
The US contributed the majority of the regions revenue, accounting for 95.2% of the weight-loss medication segment

Int J Mol Sci 2022;23:14631.ArticlePubMedPMC 86

Off-label use for low-BMI cosmetic weight loss is not supported by the evidence, exposes the patient to real risks (including rapid muscle loss and rebound after discontinuation), and typically isn't covered by insurance
How Do GLP-1 Injections Help with Medical Weight Loss

(See Fig

The GLP-1R agonists are promising candidates for the treatment of obesity
